Search
for
Sort by
Research 391–420 of 1000+
- Single‐cell transcriptomics reveals a senescence‐associated IL ‐6/ CCR6 axis driving radiodermatitis
- Alopecia areata following COVID-19 vaccine: a systematic review
- Erlotinib-Associated Alopecia in a Lung Cancer Patient
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Refractory alopecia in lupus treated with tofacitinib — a case-based review
- Drug-induced scarring and permanent alopecia
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Annual Convention in the Time of COVID
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia‐Pacific Modified Delphi Expert Panel Recommendations
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Case Report of a Patient With Psoriasis Vulgaris, Psoriatic Arthritis and Alopecia Universalis Successfully Treated With Tofacitinib and Methotrexate
- Exploring the Use of Topical Tofacitinib in Pediatric Alopecia Totalis
- Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy
- Advances in Topical Therapies for Clinically Relevant and Prevalent Forms of Alopecia
- Ponatinib-induced pityriasis rubra pilaris-like adnexal dysmaturation: A case report
- Advances in the mechanism and new therapies of alopecia areata
- Androgenetic alopecia: An update
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Tofacitinib: A Promising Treatment for Adolescent Alopecia Areata
- 22-Year-Old Male with Several Discrete Patches of Hair Loss
- DataSheet1_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF
- The Good and Bad News About New Drugs for Treating Alopecia Areata
- Diagnostic Challenges and Treatment Strategies in Neutrophilic Cicatricial Alopecias: A Narrative Review from Conventional Therapies to New Therapeutic Targets
- CURRENT UNDERSTANDING OF VITILIGO: A COMPREHENSIVE LITERATURE REVIEW
- COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists